Gut microbiota in the pathogenesis of
COVID-19: viral replication and transmission
(abridged secondary publication)
SC Ng, FKL Chan, PKS Chan, GCY Lui, JWY Mak, T Zuo, Q Liu, F Zhang
Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong SAR, China
- Prolonged and active SARS-CoV-2 virus remained in the gut of patients with COVID-19, even after recovery.
- Both gut bacterial and viral microbiota were disrupted in patients with COVID-19, persisting for up to 6 months after disease resolution.
- Several gut commensal bacteria with known immunomodulatory potential–Faecalibacterium prausnitzii, Eubacterium rectale, and Bifidobacteria–and two RNA virus species derived from pepper plants were underrepresented in these patients.
- Depletion of these bacterial and viral taxa was associated with more severe disease and higher levels of inflammatory cytokines and blood markers.